General Information
Version
Draft 2.1
Revision date
2015-04-01
Product name
NOVAREL (chorionic gonadotropin for injection, usp)
1.2.1 Relevant identified uses
Finished pharmaceutical product Ferring Pharmaceuticals Inc 100 Interpace Parkway Parsippany, NJ 07054 USA +1 973 796 1600
Emergency telephone
1-800-255-3924, +01-813-248-0585
Icons in SDS
Company Information
company name
Ferring Pharmaceuticals Inc
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H334
Hazard statements
Code
Statements
H334
May cause allergy or asthma symptoms or breathing difficulties if inhaled
Section 2
SECTION 2: Hazards identification
GHS Classification Substance or mixture classification GHS Classification in accordance with 29 CFR 1910.1200(d) Respiratory Sensitizer (Category 1) Skin Sensitizer (Category 1) Reproductive Toxicant (Category 2)
Signal word
Danger
Hazard statements
May cause allergy or asthma symptoms or breathing difficulties if inhaled. May cause an allergic skin reaction Suspected of damaging fertility or the unborn child.
Prevention
Avoid breathing product. Review product insert instructions prior to use. Do not handle until all safety precautions have been read and understood. Wear nitrile gloves when handling. Contaminated work clothing must not be allowed out of the workplace.
Response
If on skin: Wash with plenty of water. If skin irritation or rash occurs: Get medical advice/attention. If inhaled: If breathing is difficult, remove person to fresh air and keep comfortable for breathing. If experiencing respiratory symptoms: get medical advice/attention. If exposed or concerned: Get medical advice/attention. Wash contaminated clothing before reuse.
Storage
Store under access control conditions.
Disposal
Dispose of any lyocakes in accordance with local regulations.
2.3 Other hazards
- none
2.1 Classification of the substance or mixture
GHS Classification in accordance with 29 CFR 1910.1200(d) Respiratory Sensitizer (Category 1) Skin Sensitizer (Category 1) Reproductive Toxicant (Category 2)
